IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Athyrium Capital Management, LP

Q3 2019 Holdings

Filed 2019-11-14 | 1 holdings | $5.1K | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Kala Pharmaceuticals IncCOM483119103$5.1K1,333,333100.0%